Literature DB >> 33681267

Decision Tree With Only Two Musculoskeletal Sites to Diagnose Polymyalgia Rheumatica Using [18F]FDG PET-CT.

Anthime Flaus1, Julie Amat2, Nathalie Prevot1,3, Louis Olagne4, Lucie Descamps5, Clément Bouvet2, Bertrand Barres2, Clémence Valla2, Sylvain Mathieu5, Marc Andre4, Martin Soubrier5, Charles Merlin2, Antony Kelly2, Marion Chanchou2, Florent Cachin2.   

Abstract

Introduction: The aim of this study was to find the best ordered combination of two FDG positive musculoskeletal sites with a machine learning algorithm to diagnose polymyalgia rheumatica (PMR) vs. other rheumatisms in a cohort of patients with inflammatory rheumatisms.
Methods: This retrospective study included 140 patients who underwent [18F]FDG PET-CT and whose final diagnosis was inflammatory rheumatism. The cohort was randomized, stratified on the final diagnosis into a training and a validation cohort. FDG uptake of 17 musculoskeletal sites was evaluated visually and set positive if uptake was at least equal to that of the liver. A decision tree classifier was trained and validated to find the best combination of two positives sites to diagnose PMR. Diagnosis performances were measured first, for each musculoskeletal site, secondly for combination of two positive sites and thirdly using the decision tree created with machine learning.
Results: 55 patients with PMR and 85 patients with other inflammatory rheumatisms were included. Musculoskeletal sites, used either individually or in combination of two, were highly imbalanced to diagnose PMR with a high specificity and a low sensitivity. The machine learning algorithm identified an optimal ordered combination of two sites to diagnose PMR. This required a positive interspinous bursa or, if negative, a positive trochanteric bursa. Following the decision tree, sensitivity and specificity to diagnose PMR were respectively 73.2 and 87.5% in the training cohort and 78.6 and 80.1% in the validation cohort.
Conclusion: Ordered combination of two visually positive sites leads to PMR diagnosis with an accurate sensitivity and specificity vs. other rheumatisms in a large cohort of patients with inflammatory rheumatisms.
Copyright © 2021 Flaus, Amat, Prevot, Olagne, Descamps, Bouvet, Barres, Valla, Mathieu, Andre, Soubrier, Merlin, Kelly, Chanchou and Cachin.

Entities:  

Keywords:  [18F]FDG PET-CT; decision-tree algorithm; inflammatory rheumatism; machine learning; polymyalgia rheumatica

Year:  2021        PMID: 33681267      PMCID: PMC7928279          DOI: 10.3389/fmed.2021.646974

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  3 in total

1.  Diagnostic accuracy and validation of 18F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica.

Authors:  Lien Moreel; Lennert Boeckxstaens; Albrecht Betrains; Maarten Van Hemelen; Steven Vanderschueren; Koen Van Laere; Daniel Blockmans
Journal:  Front Med (Lausanne)       Date:  2022-09-21

Review 2.  Indications for diagnostic use of nuclear medicine in rheumatology: A mini-review.

Authors:  Martin Wenger; Michael Schirmer
Journal:  Front Med (Lausanne)       Date:  2022-09-28

3.  Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica.

Authors:  Kornelis S M van der Geest; Yannick van Sleen; Pieter Nienhuis; Maria Sandovici; Nynke Westerdijk; Andor W J M Glaudemans; Elisabeth Brouwer; Riemer H J A Slart
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.